Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Looking into the crystal ball: biomarkers for outcomes of HBV infection.

Literature DB >> 26732689

Looking into the crystal ball: biomarkers for outcomes of HBV infection.

Hung-Chih Yang^1,2,3, Jia-Horng Kao^4,5,6.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2016 PMID： 26732689 DOI： 10.1007/s12072-015-9698-x

Source DB: PubMed Journal: Hepatol Int ISSN： 1936-0533 Impact factor: 6.047

× No keyword cloud information.

18 in total

1. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

Authors: Maurizia Rossana Brunetto; Filippo Oliveri; Piero Colombatto; Francesco Moriconi; Pietro Ciccorossi; Barbara Coco; Veronica Romagnoli; Beatrice Cherubini; Giovanna Moscato; Anna Maria Maina; Daniela Cavallone; Ferruccio Bonino
Journal: Gastroenterology Date: 2010-05-05 Impact factor: 22.682

2. A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.

Authors: Wai-Kay Seto; Danny Ka-Ho Wong; James Fung; Ivan Fan-Ngai Hung; Daniel Yee-Tak Fong; John Chi-Hang Yuen; Teresa Tong; Ching-Lung Lai; Man-Fung Yuen
Journal: Hepatology Date: 2012-07-10 Impact factor: 17.425

3. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Authors: Tai-Chung Tseng; Chun-Jen Liu; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal: Gastroenterology Date: 2011-04-28 Impact factor: 22.682

Review 4. Perspectives and control of hepatitis B virus infection in Taiwan.

Authors: Chih-Lin Lin; Jia-Horng Kao
Journal: J Formos Med Assoc Date: 2015-07-13 Impact factor: 3.282

5. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.

Authors: Li Wang; Zhi-Qiang Zou; Kai Wang; Ji-Guang Yu; Xiang-Zhong Liu
Journal: Hepatol Int Date: 2015-10-01 Impact factor: 6.047

Review 6. Global control of hepatitis B virus infection.

Authors: Jia-Horng Kao; Ding-Shinn Chen
Journal: Lancet Infect Dis Date: 2002-07 Impact factor: 25.071

7. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

Authors: Tai-Chung Tseng; Chun-Jen Liu; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal: Gastroenterology Date: 2012-02-11 Impact factor: 22.682

8. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

Authors: Mei-Hsuan Lee; Hwai-I Yang; Jessica Liu; Richard Batrla-Utermann; Chin-Lan Jen; Uchenna H Iloeje; Sheng-Nan Lu; San-Lin You; Li-Yu Wang; Chien-Jen Chen
Journal: Hepatology Date: 2013-08 Impact factor: 17.425

9. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.

Authors: Tai-Chung Tseng; Chun-Jen Liu; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Cheng-An Hsu; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal: Hepatology Date: 2012-12-06 Impact factor: 17.425

Looking into the crystal ball: biomarkers for outcomes of HBV infection.

1. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

2. A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.

3. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Review 4. Perspectives and control of hepatitis B virus infection in Taiwan.

5. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.

Review 6. Global control of hepatitis B virus infection.

7. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

8. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

9. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.

10. Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B.

1. Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace.

Review 2. Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives.

Review 3. Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.

Review 4. New perspectives of biomarkers for the management of chronic hepatitis B.

Review 5. The Role of Hepatitis B Core-Related Antigen.

Review 6. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi.

Review 7. Novel biomarkers for the management of chronic hepatitis B.